Netherlands’ Norgine Sets Up OTC Business And Targets Acquisitions
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.